2024-05-012025-04-302025-04-30false14827421ECO2LIFE CO. LTD2025-12-0346900falseiso4217:GBPxbrli:pure148274212024-04-30148274212025-04-30148274212024-05-012025-04-30148274212023-04-24148274212024-04-30148274212023-04-252024-04-3014827421bus:SmallEntities2024-05-012025-04-3014827421bus:AuditExempt-NoAccountantsReport2024-05-012025-04-3014827421bus:FullAccounts2024-05-012025-04-3014827421bus:PrivateLimitedCompanyLtd2024-05-012025-04-3014827421core:WithinOneYear2025-04-3014827421core:AfterOneYear2025-04-3014827421core:WithinOneYear2024-04-3014827421core:AfterOneYear2024-04-3014827421core:ShareCapital2025-04-3014827421core:SharePremium2025-04-3014827421core:RevaluationReserve2025-04-3014827421core:OtherReservesSubtotal2025-04-3014827421core:RetainedEarningsAccumulatedLosses2025-04-3014827421core:ShareCapital2024-04-3014827421core:SharePremium2024-04-3014827421core:RevaluationReserve2024-04-3014827421core:OtherReservesSubtotal2024-04-3014827421core:RetainedEarningsAccumulatedLosses2024-04-3014827421core:LandBuildings2025-04-3014827421core:PlantMachinery2025-04-3014827421core:Vehicles2025-04-3014827421core:FurnitureFittings2025-04-3014827421core:OfficeEquipment2025-04-3014827421core:NetGoodwill2025-04-3014827421core:IntangibleAssetsOtherThanGoodwill2025-04-3014827421core:ListedExchangeTraded2025-04-3014827421core:UnlistedNon-exchangeTraded2025-04-3014827421core:LandBuildings2024-04-3014827421core:PlantMachinery2024-04-3014827421core:Vehicles2024-04-3014827421core:FurnitureFittings2024-04-3014827421core:OfficeEquipment2024-04-3014827421core:NetGoodwill2024-04-3014827421core:IntangibleAssetsOtherThanGoodwill2024-04-3014827421core:ListedExchangeTraded2024-04-3014827421core:UnlistedNon-exchangeTraded2024-04-3014827421core:LandBuildings2024-05-012025-04-3014827421core:PlantMachinery2024-05-012025-04-3014827421core:Vehicles2024-05-012025-04-3014827421core:FurnitureFittings2024-05-012025-04-3014827421core:OfficeEquipment2024-05-012025-04-3014827421core:NetGoodwill2024-05-012025-04-3014827421core:IntangibleAssetsOtherThanGoodwill2024-05-012025-04-3014827421core:ListedExchangeTraded2024-05-012025-04-3014827421core:UnlistedNon-exchangeTraded2024-05-012025-04-3014827421core:MoreThanFiveYears2024-05-012025-04-3014827421core:Non-currentFinancialInstruments2025-04-3014827421core:Non-currentFinancialInstruments2024-04-3014827421dpl:CostSales2024-05-012025-04-3014827421dpl:DistributionCosts2024-05-012025-04-3014827421core:LandBuildings2024-05-012025-04-3014827421core:PlantMachinery2024-05-012025-04-3014827421core:Vehicles2024-05-012025-04-3014827421core:FurnitureFittings2024-05-012025-04-3014827421core:OfficeEquipment2024-05-012025-04-3014827421dpl:AdministrativeExpenses2024-05-012025-04-3014827421core:NetGoodwill2024-05-012025-04-3014827421core:IntangibleAssetsOtherThanGoodwill2024-05-012025-04-3014827421dpl:GroupUndertakings2024-05-012025-04-3014827421dpl:ParticipatingInterests2024-05-012025-04-3014827421dpl:GroupUndertakingscore:ListedExchangeTraded2024-05-012025-04-3014827421core:ListedExchangeTraded2024-05-012025-04-3014827421dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-05-012025-04-3014827421core:UnlistedNon-exchangeTraded2024-05-012025-04-3014827421dpl:CostSales2023-04-252024-04-3014827421dpl:DistributionCosts2023-04-252024-04-3014827421core:LandBuildings2023-04-252024-04-3014827421core:PlantMachinery2023-04-252024-04-3014827421core:Vehicles2023-04-252024-04-3014827421core:FurnitureFittings2023-04-252024-04-3014827421core:OfficeEquipment2023-04-252024-04-3014827421dpl:AdministrativeExpenses2023-04-252024-04-3014827421core:NetGoodwill2023-04-252024-04-3014827421core:IntangibleAssetsOtherThanGoodwill2023-04-252024-04-3014827421dpl:GroupUndertakings2023-04-252024-04-3014827421dpl:ParticipatingInterests2023-04-252024-04-3014827421dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-252024-04-3014827421core:ListedExchangeTraded2023-04-252024-04-3014827421dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-252024-04-3014827421core:UnlistedNon-exchangeTraded2023-04-252024-04-3014827421core:NetGoodwill2025-04-3014827421core:IntangibleAssetsOtherThanGoodwill2025-04-3014827421core:LandBuildings2025-04-3014827421core:PlantMachinery2025-04-3014827421core:Vehicles2025-04-3014827421core:FurnitureFittings2025-04-3014827421core:OfficeEquipment2025-04-3014827421core:AfterOneYear2025-04-3014827421core:WithinOneYear2025-04-3014827421core:ListedExchangeTraded2025-04-3014827421core:UnlistedNon-exchangeTraded2025-04-3014827421core:ShareCapital2025-04-3014827421core:SharePremium2025-04-3014827421core:RevaluationReserve2025-04-3014827421core:OtherReservesSubtotal2025-04-3014827421core:RetainedEarningsAccumulatedLosses2025-04-3014827421core:NetGoodwill2024-04-3014827421core:IntangibleAssetsOtherThanGoodwill2024-04-3014827421core:LandBuildings2024-04-3014827421core:PlantMachinery2024-04-3014827421core:Vehicles2024-04-3014827421core:FurnitureFittings2024-04-3014827421core:OfficeEquipment2024-04-3014827421core:AfterOneYear2024-04-3014827421core:WithinOneYear2024-04-3014827421core:ListedExchangeTraded2024-04-3014827421core:UnlistedNon-exchangeTraded2024-04-3014827421core:ShareCapital2024-04-3014827421core:SharePremium2024-04-3014827421core:RevaluationReserve2024-04-3014827421core:OtherReservesSubtotal2024-04-3014827421core:RetainedEarningsAccumulatedLosses2024-04-3014827421core:NetGoodwill2023-04-2414827421core:IntangibleAssetsOtherThanGoodwill2023-04-2414827421core:LandBuildings2023-04-2414827421core:PlantMachinery2023-04-2414827421core:Vehicles2023-04-2414827421core:FurnitureFittings2023-04-2414827421core:OfficeEquipment2023-04-2414827421core:AfterOneYear2023-04-2414827421core:WithinOneYear2023-04-2414827421core:ListedExchangeTraded2023-04-2414827421core:UnlistedNon-exchangeTraded2023-04-2414827421core:ShareCapital2023-04-2414827421core:SharePremium2023-04-2414827421core:RevaluationReserve2023-04-2414827421core:OtherReservesSubtotal2023-04-2414827421core:RetainedEarningsAccumulatedLosses2023-04-2414827421core:AfterOneYear2024-05-012025-04-3014827421core:WithinOneYear2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:CostValuation2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-012025-04-3014827421core:Non-currentFinancialInstrumentscore:CostValuation2025-04-3014827421core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-3014827421core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-3014827421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-3014827421core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-3014827421core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-3014827421core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-3014827421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-3014827421core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-3014827421core:Non-currentFinancialInstrumentscore:CostValuation2024-04-3014827421core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-3014827421core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-3014827421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-3014827421core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-3014827421core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-3014827421core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-3014827421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-3014827421core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-3014827421bus:Director12024-05-012025-04-30

ECO2LIFE CO. LTD

Registered Number
14827421
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2025

ECO2LIFE CO. LTD
Company Information
for the year from 1 May 2024 to 30 April 2025

Director

LI, Qingwen

Company Secretary

LI, Qingwen

Registered Address

71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

Registered Number

14827421 (England and Wales)
ECO2LIFE CO. LTD
Statement of Financial Position
30 April 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets34,1331,241
4,1331,241
Current assets
Debtors445,1768,273
Cash at bank and on hand53,47029,584
98,64637,857
Creditors amounts falling due within one year5(37,538)(1,978)
Net current assets (liabilities)61,10835,879
Total assets less current liabilities65,24137,120
Net assets65,24137,120
Capital and reserves
Called up share capital50,00050,000
Profit and loss account15,241(12,880)
Shareholders' funds65,24137,120
The financial statements were approved and authorised for issue by the Director on 3 December 2025, and are signed on its behalf by:
LI, Qingwen
Director
Registered Company No. 14827421
ECO2LIFE CO. LTD
Notes to the Financial Statements
for the year ended 30 April 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A, as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred. The company carried out qualifying research and development (R&D) activities during the year and claimed a Research and Development Expenditure Credit (RDEC) under the merged RDEC scheme.
Tangible fixed assets and depreciation
Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount. Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year31
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 May 241,6541,654
Additions3,3673,367
At 30 April 255,0215,021
Depreciation and impairment
At 01 May 24413413
Charge for year475475
At 30 April 25888888
Net book value
At 30 April 254,1334,133
At 30 April 241,2411,241
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables33,4624,136
Other debtors11,7144,137
Total45,1768,273
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables1,7191,973
Amounts owed to related parties55
Other creditors3,157-
Accrued liabilities and deferred income32,657-
Total37,5381,978